Antibody Response to the SARS-CoV-2 Spike and Nucleocapsid Proteins in Patients with Different COVID-19 Clinical Profiles

The first case of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in Brazil was diagnosed on February 26, 2020. Due to the important epidemiological impact of COVID-19, the present study aimed to analyze the specificity of IgG antibody res...

Descripción completa

Detalles Bibliográficos
Autores principales: Soares, Sinei Ramos, da Silva Torres, Maria Karoliny, Lima, Sandra Souza, de Sarges, Kevin Matheus Lima, dos Santos, Erika Ferreira, de Brito, Mioni Thieli Figueiredo Magalhães, da Silva, Andréa Luciana Soares, de Meira Leite, Mauro, da Costa, Flávia Póvoa, Cantanhede, Marcos Henrique Damasceno, da Silva, Rosilene, de Oliveira Lameira Veríssimo, Adriana, Vallinoto, Izaura Maria Vieira Cayres, Feitosa, Rosimar Neris Martins, Quaresma, Juarez Antônio Simões, Chaves, Tânia do Socorro Souza, Viana, Giselle Maria Rachid, Falcão, Luiz Fábio Magno, dos Santos, Eduardo José Melo, Vallinoto, Antonio Carlos Rosário, da Silva, Andréa Nazaré Monteiro Rangel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141342/
https://www.ncbi.nlm.nih.gov/pubmed/37112878
http://dx.doi.org/10.3390/v15040898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141342/
https://www.ncbi.nlm.nih.gov/pubmed/37112878
http://dx.doi.org/10.3390/v15040898

Ejemplares similares